反応式
Br[C:2]1[O:3][C:4]([C:7]#[N:8])=[CH:5][CH:6]=1.[CH3:9][C:10]1([CH3:24])[C:15]2[CH:16]=[C:17](B(O)O)[CH:18]=[CH:19][C:14]=2[NH:13][C:12](=[O:23])[O:11]1>>[CH3:9][C:10]1([CH3:24])[O:11][C:12](=[O:23])[NH:13][C:14]2[CH:19]=[CH:18][C:17]([C:2]3[O:3][C:4]([C:7]#[N:8])=[CH:5][CH:6]=3)=[CH:16][C:15]1=2参加物
3
実験手順
The title compound was prepared according to the procedure B from 2-bromo-5-cyanofuran (1.0 g, 5.6 mmol) (J. Med. Chem. (1997), 40(23),3804-3819) and (1,4-dihydro-4,4-dimethyl-2-oxo-2H-3,1-benzoxazin-6-yl)boronic acid (1.8 g, 8.18 mmol) as a white solid (0.39 g, 1.45 mmol, 17%): mp. 257-260° C. 1H-NMR (DMSO-d6) δ 10.48 (s, 1H), 7.73-7.70 (m, 3H), 7.19 (d, 1H, J=3.8 Hz), 6.98 (d, 1H, J=8.9 Hz), 1.66 (s, 6H); MS ((+)−APCI) m/z=269 (M+H)+.
出典と根拠
- ORDレコード
- ord-370dba5124cf4574a0085feaf4cbee27
- 出典データセット
- uspto-grants-2004_03
- 特許番号
- US06713478B2
関連ノート
読み込み中…